APP and Alzheimer disease: In multiple mouse models of AD, including 3xTg-AD [21], AppNL−F/NL−F [22], and APP/PS1 [23] mice, chronic HFD feeding was found to increase microglia reactivity in the hippocampus and impair microglia β-amyloid (Aβ) plaque clearance.